Infections caused by invasive intracellular bacteria pose major therapeutic challenges due to pathogen survival and growth inside of host cells as well as the low intracellular accessibility for conventional antibiotics. The limited ability of most antibiotics to enter intracellular compartments underscores the urgent need for innovative antimicrobial agents capable of overcoming these barriers. In this study, the antibacterial peptide Pac525 was synthesized with the RGD domain to facilitate efficient penetration into eukaryotic cells. The efficacy and safety of RGD-Pac525 was evaluated in intracellular infection models, using the macrophage cell line RAW 264.7, chicken intestinal organoids, and chicken embryo tissues via the chorioallantoic membrane (CAM). Our findings from cell line experiments demonstrate that the RGD-Pac525 peptide retained the antimicrobial properties of the original peptide without compromising its efficacy. While RGD-Pac525 reduced the intracellular adherent-invasive pathogen Escherichia coli KV203 by 50% in RAW 264.7 macrophage cells, it did not adversely affect the macrophage viability. Additionally, RGD-Pac525 effectively reduced the intracellular bacterial burden in organoids, without compromising their structural integrity. In ovo bioassays, a substantial reduction in the bacterial load was observed in liver and intestinal tissues, indicating the peptide ability to achieve systemic distribution and to overcome tissue barriers. RGD-Pac525 was effective in infection models by suppressing bacterial growth. Preliminary observations suggest it may also affect host responses, indicating a potential for combined antimicrobial and therapeutic effects that warrant further studies. This study provides a compelling proof of concept for utilizing RGD-modified antimicrobial peptides for treatment of intracellular bacterial infections.

Department of Chemistry and Biochemistry Mendel University in Brno Zemedelska 1 613 00 Brno Czech Republic

Department of Microbiology Nutrition and Dietetics Czech University of Life Sciences Prague Czech Republic

Faculty of Medicine in Pilsen Biomedical Center Charles University Pilsen Czech Republic

Zobrazit více v PubMed

Kaufmann, S. H. E. Intracellular pathogens: living in an extreme environment. PubMed DOI

Thakur, A., Mikkelsen, H. & Jungersen, G. Intracellular pathogens: Host immunity and microbial persistence strategies. PubMed PMC

Anderson, G., Dodson, K., Hooton, T. & Hultgren, S. Intracellular bacterial communities of uropathogenic in urinary tract pathogenesis. PubMed DOI

Conover, M. S. et al. Metabolic requirements of PubMed DOI PMC

Kaper, J. B., Nataro, J. P. & Mobley, H. L. T. Pathogenic PubMed DOI

Conte, M. P. et al. Adherent-invasive PubMed DOI PMC

Darfeuille-Michaud, A. et al. Presence of adherent PubMed DOI

Darfeuille-Michaud, A. et al. High prevalence of adherent-invasive PubMed DOI

Darfeuille-Michaud, A. Adherent-invasive PubMed DOI

Buccini, D. F., Cardoso, M. H. & Franco, O. L. Antimicrobial peptides and Cell-Penetrating peptides for treating intracellular bacterial infections. PubMed DOI PMC

Van Bambeke, F., Barcia-Macay, M., Lemaire, S. & Tulkens, P. M. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. PubMed

Dalhoff, A., Schubert, S. & Ullmann, U. Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide. PubMed DOI

Morales, L. D., Av-Gay, Y. & Murphy, M. E. P. Acidic pH modulates PubMed DOI PMC

Nussbaumer-Pröll, A. K. et al. Low pH reduces the activity of ceftolozane/tazobactam in human urine, but confirms current breakpoints for urinary tract infections. PubMed DOI

Nussbaumer-Pröll, A. K., Eberl, S., Schober, C. & Zeitlinger, M. Impact of pH on the activity of novel cephalosporin Cefiderocol in human urine. PubMed DOI PMC

Smith, C. B., Evavold, C. & Kersh, G. J. The effect of pH on antibiotic efficacy against Coxiella burnetii in axenic media. PubMed DOI PMC

Carryn, S. et al. Intracellular pharmacodynamics of antibiotics. PubMed DOI

Lewies, A., Du Plessis, L. H. & Wentzel, J. F. Antimicrobial peptides: the achilles’ heel of antibiotic resistance? PubMed DOI

Magana, M. et al. The value of antimicrobial peptides in the age of resistance. PubMed DOI

Moravej, H. et al. Antimicrobial peptides: features, action, and their resistance mechanisms in Bacteria. PubMed DOI

Rima, M. et al. Antimicrobial peptides: A potent alternative to antibiotics. PubMed DOI PMC

Steinstraesser, L., Kraneburg, U., Jacobsen, F. & Al-Benna Host defense peptides and their antimicrobial-immunomodulatory duality. PubMed DOI

Mba, I. E. & Nweze, E. I. Antimicrobial peptides therapy: an emerging alternative for treating Drug-Resistant Bacteria. PubMed PMC

Mookherjee, N. & Hancock, R. E. W. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. PubMed DOI PMC

Cudic, M. & Otvos, L. Jr. Intracellular targets of antibacterial peptides. PubMed DOI

Ludwig, B. S., Kessler, H., Kossatz, S. & Reuning, U. RGD-Binding integrins revisited: how recently discovered functions and novel synthetic ligands (Re-)Shape an Ever-Evolving field. PubMed DOI PMC

Wang, F. et al. The functions and applications of RGD in tumor therapy and tissue engineering. PubMed DOI PMC

Erdem Büyükkiraz, M. & Kesmen, Z. Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds. PubMed DOI

Ahn, M. J. et al. Enhancement of antibacterial activity of short Tryptophan-rich antimicrobial peptide Pac-525 by replacing trp with His(chx). DOI

Lau, Q. Y. et al. A Head-to-Head comparison of the antimicrobial activities of 30 Ultra-Short antimicrobial peptides against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans. DOI

Qi, X. et al. Novel short antibacterial and antifungal peptides with low cytotoxicity: efficacy and action mechanisms. PubMed DOI

Wei, S. Y. et al. Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity. PubMed DOI PMC

Cuperus, T., Van Dijk, A., Matthijs, M. G. R., Veldhuizen, E. J. A. & Haagsman, H. P. Protective effect of in Ovo treatment with the chicken Cathelicidin analog D-CATH-2 against avian pathogenic E. coli. PubMed DOI PMC

Nguyen, T. T. T. et al. Avian antimicrobial peptides: in vitro and in Ovo characterization and protection from early chick mortality caused by yolk sac infection. PubMed DOI PMC

Verma, S., Senger, S., Cherayil, B. J. & Faherty, C. S. Spheres of influence: insights into Salmonella pathogenesis from intestinal organoids. PubMed DOI PMC

Zhang, Y. & Sun, J. Study Bacteria–Host interactions using intestinal organoids. In PubMed PMC

Divya, M. et al. Biopolymer gelatin-coated zinc oxide nanoparticles showed high antibacterial, antibiofilm and anti-angiogenic activity. PubMed DOI

Mitchell, J. et al. Chicken intestinal organoids: a novel method to measure the mode of action of feed additives. PubMed DOI PMC

Chen, K. et al. Requirement of CRAMP for mouse macrophages to eliminate phagocytosed PubMed DOI PMC

Bosák, J. et al. Escherichia coli from biopsies differ in virulence genes between patients with colorectal neoplasia and healthy controls. PubMed DOI PMC

ISO. ISO 10993-5:2009 - Biological Evaluation of Medical Devices—Part 5: Tests for in Vitro Cytotoxicity. vol. ISO 10993-5:2009 34 (2009).

Elsinghorst, E. A. Measurement of invasion by gentamicin resistance. In PubMed

Bio-Rad Laboratories. Electroporation of

Li, J. et al. Culture and characterization of chicken small intestinal crypts. PubMed DOI

Merlos Rodrigo, M. A. et al. Extending the applicability of in Ovo and ex Ovo chicken Chorioallantoic membrane assays to study cytostatic activity in neuroblastoma cells. PubMed DOI PMC

He, Y. et al. An antimicrobial Peptide-Loaded gelatin/chitosan nanofibrous membrane fabricated by sequential Layer-by-Layer electrospinning and electrospraying techniques. PubMed DOI PMC

He, Y. et al. Development of an antimicrobial peptide-loaded mineralized collagen bone scaffold for infective bone defect repair. PubMed DOI PMC

He, Y. et al. A novel antibacterial titanium modification with a sustained release of Pac-525. PubMed DOI PMC

He, Y. et al. Composite mineralized collagen/polycaprolactone Scaffold-Loaded microsphere system with dual osteogenesis and antibacterial functions. PubMed DOI PMC

Li, J. et al. High in vitro antibacterial activity of Pac-525 against PubMed PMC

Zhang, Z. et al. Construction and characterizations of antibacterial surfaces based on Self-Assembled monolayer of antimicrobial peptides (Pac-525) derivatives on gold. DOI

Temming, K., Schiffelers, R. M., Molema, G. & Kok, R. J. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. PubMed DOI

Abd El-Azeem, S. H., Khalil, A. A., Ibrahim, M. A. M. & Gamal, A. Y. The use of integrin binding domain loaded hydrogel (RGD) with minimally invasive surgical technique in treatment of periodontal intrabony defect: a randomized clinical and biochemical study. PubMed DOI PMC

Colin, M. et al. Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. PubMed DOI

Cossu, J., Thoreau, F. & Boturyn, D. Multimeric RGD-based strategies for selective drug delivery to tumor tissues. PubMed DOI PMC

He, M. et al. Spatiotemporally controllable diphtheria toxin expression using a light-switchable transgene system combining multifunctional nanoparticle delivery system for targeted melanoma therapy. PubMed DOI

Chen, C. W., Lu, Yeh, S. & Chiang Novel RGD-lipid conjugate-modified liposomes for enhancing SiRNA delivery in human retinal pigment epithelial cells. PubMed PMC

Jain, S. et al. RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. PubMed DOI

Javid, H. et al. RGD peptide in cancer targeting: benefits, challenges, solutions, and possible integrin–RGD interactions. PubMed DOI PMC

Shen, Z. et al. Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma. PubMed DOI PMC

Wang, D. B. et al. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ3 for staging liver fibrosis in rat model. PubMed PMC

Zhan, C. et al. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances Paclitaxel anti-glioblastoma effect. PubMed DOI

Manjusha, V., Reshma, L. R. & Anirudhan, T. S. Mesoporous silica gated mixed micelle for the targeted co-delivery of doxorubicin and Paclitaxel. DOI

Raut, S. Y. et al. Engineered nano-carrier systems for the oral targeted delivery of follicle stimulating hormone: development, characterization, and, assessment of in vitro and in vivo performance and targetability. PubMed DOI

Thakur, R., Suri, C. R., Kaur, I. P. & Rishi, P. Peptides as diagnostic, therapeutic, and theranostic tools: progress and future challenges. PubMed DOI

Xu, Z. et al. RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy. PubMed DOI PMC

Kemker, I., Feiner, R. C., Müller, K. M. & Sewald, N. Size-dependent cellular uptake of RGD peptides. PubMed PMC

Diaferia, C., Rosa, E., Accardo, A. & Morelli, G. Peptide-based hydrogels as delivery systems for doxorubicin. PubMed DOI

He, T. et al. Dual-stimuli-responsive nanotheranostics for dual-targeting photothermal-enhanced chemotherapy of tumor. PubMed DOI

Juan, H. F. et al. Proteomics analysis of a novel compound: Cyclic RGD in breast carcinoma cell line MCF-7. PubMed

Duarte-Mata, D. I. & Salinas-Carmona, M. C. Antimicrobial peptides´ immune modulation role in intracellular bacterial infection. PubMed DOI PMC

Fang, Y. & Eglen, R. M. Three-dimensional cell cultures in drug discovery and development. PubMed DOI PMC

Yan, J., Monlong, J., Cougoule, C., Lacroix-Lamandé, S. & Wiedemann, A. Mapping the scientific output of organoids for animal and human modeling infectious diseases: a bibliometric assessment. PubMed DOI PMC

Yao, Q. et al. Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine. PubMed DOI PMC

Bozzetti, V. & Senger, S. Organoid technologies for the study of intestinal microbiota–host interactions. PubMed DOI PMC

Forbester, J. L. et al. Interaction of Salmonella enterica serovar typhimurium with intestinal organoids derived from human induced pluripotent stem cells. PubMed DOI PMC

Nickerson, K. P. et al. A versatile human intestinal organoid-derived epithelial monolayer model for the study of enteric pathogens. PubMed DOI PMC

Schafer, S. T. et al. An in vivo neuroimmune organoid model to study human microglia phenotypes. PubMed DOI PMC

Alnassan, A. A. et al. Embryonated chicken eggs as an alternative model for mixed Clostridium perfringens and Eimeria Tenella infection in chickens. PubMed DOI

Ribeiro, L. N. M., Schlemper, A. E., da Silva, M. V. & Fonseca, B. B. Chicken embryo: a useful animal model for drug testing? PubMed

Rezaee, M. S., Liebhart, D., Hess, C., Hess, M. & Paudel, S. Bacterial infection in chicken embryos and consequences of yolk sac constitution for embryo survival. PubMed DOI

Li, G. et al. cRGD enables rapid phagocytosis of liposomal Vancomycin for intracellular bacterial clearance. PubMed DOI

Kember, M., Grandy, S., Raudonis, R. & Cheng, Z. Non-Canonical host intracellular niche links to new antimicrobial resistance mechanism. PubMed DOI PMC

Pollet, I. et al. Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-κB and c-Jun N-terminal kinase. PubMed DOI

Safari, Z. et al. Promotion of angiogenesis by M13 phage and RGD peptide in vitro and in vivo. PubMed DOI PMC

Kühl, L. et al. Human lung Organoids—A novel experimental and precision medicine approach. PubMed DOI PMC